Cover Feature: Novel Vancomycin‐β‐Lactam Hybrids: Structure–Activity Relationships and Therapeutic Potential Against VISA and VRE (ChemMedChem 6/2026)
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The cover illustrates a novel vancomycin–β-lactam hybrid antibiotic simultaneously targeting Lipid II and PBP on the bacterial cell membrane, thereby exerting a synergistic antibacterial effect through dual inhibition of cell wall biosynthesis. In the Research article (DOI: 10.1002/cmdc.202501084), Chengtao Feng, Xiaowen Wang, Dongliang Guan, and co-workers systematically constructed and evaluated a series of hybrid molecules, identifying the C-terminally modified compound 6a as exhibiting significantly enhanced antibacterial activity against resistant strains such as VISA and VRE. These findings provide a promising strategy for the development of next-generation antibiotics against antimicrobial resistance. The inspiration for this cover design comes from Dongliang Guan.
Fields of Study & Subjects
Antimicrobial Resistance in Staphylococcus
Antibiotic Resistance in Bacteria
Antimicrobial Peptides and Activities
Publication details
- Journal / source
- ChemMedChem
- Volume
- 21
- Issue
- 6
- Pages
- e70276
- Publication date
- 27 March 2026
- Language
- EN